Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial.

Title:: Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial.
Document type:: Published Erratum
Author(s):: Wanner, Christoph; Cooper, Mark E; Johansen, Odd Erik; Toto, Robert; Rosenstock, Julio; McGuire, Darren K; Kahn, Steven E; Pfarr, Egon; Schnaidt, Sven; von Eynatten, Maximilian; George, Jyothis T; Gollop, Nicholas D; Marx, Nikolaus; Alexander, John H; Zinman, Bernard; Perkovic, Vlado
Abstract:: [This corrects the article DOI: 10.1093/ckj/sfaa225.].
Journal title abbreviation:: Clin Kidney J
Year:: 2021
Journal volume:: 14
Journal issue:: 9
Fulltext / DOI:: doi:10.1093/ckj/sfab104
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/34476096
Print-ISSN:: 2048-8505
TUM Institution:: Fachgebiet Nephrologie (Prof. Heemann)
BibTeX

Occurrences: